For buyers

Regulatory approval timeline for buyers

Federal and state law current as of September 2026 — verify with counsel.

Key takeaways

  • As of September 2026, medical marijuana is Schedule III; adult-use remains Schedule I (Federal Register 2026-08176 and pending hearing).
  • 280E still hits adult-use SG&A; medical books may take ordinary deductions — apportion dual licenses.
  • SBA loans are unavailable for plant-touching targets (SOP 50 10 8).
  • Deals close on regulatory approval; control does not move early.
  • Single-store commentary multiples of about 3x–6x EBITDA are trade ranges, not appraisals (2025–2026 commentary).

Regulatory approval timeline for buyers is a buyer-side eligibility and verification problem. A cheap license you cannot own, finance, or operate at that address is not an acquisition. It is a legal bill. This page is written for buyers and for more than one license class. It is not legal or tax advice.

Jason Taken will not price Regulatory approval timeline for buyers on a rumor that “rescheduling is done.” Medical rescheduling is done for the activity the order covers. Adult-use is not. FinCEN FIN-2014-G001 and SBA SOP 50 10 8 did not disappear in April 2026. H.R.9471 is the House companion, also unenacted.

TopicWorking rule (verify, September 2026)
Audiencebuyers
License lensmore than one license class
Contrast marketsMichigan / Ohio / Maryland
SBAUnavailable for plant-touching (SOP 50 10 8)
Hemp clockP.L. 119-37 redefinition 12 November 2026
Commentary multiple (not an appraisal)3x–33x normalized earnings

How HedgeStone treats Regulatory approval timeline for buyers — what should you verify for Regulatory approval timeline for buyers?

Jason Taken will say if Regulatory approval timeline for buyers is transferable before anyone writes a CIM. He is a business broker, not an attorney and not a licensed operator. No invented listings, no invented MSO names.

Successor liability sitting under Regulatory approval timeline for buyers — why does this change Regulatory approval timeline for buyers?

Cannabis tax debt does not vanish because someone chose an asset sale. Clearance certificates and holdbacks exist for Regulatory approval timeline for buyers. See tax holdbacks.

Banking after Regulatory approval timeline for buyers — what should you verify for Regulatory approval timeline for buyers?

FinCEN FIN-2014-G001 is still the SAR frame. A new owner who assumes the seller’s bank will keep the account is guessing. Model cash handling until the successor account is real.

When to walk away from Regulatory approval timeline for buyers — why does this change Regulatory approval timeline for buyers?

If the license is locked, the city will not host the buyer, the books cannot be rebuilt, or the hemp catalog dies in November 2026, the honest answer is stop. Regulatory approval timeline for buyers is not improved by optimism.

Partner and dispute uses of Regulatory approval timeline for buyers — how should you read this on Regulatory approval timeline for buyers?

Buyouts and shareholder fights still need a method, not a slogan. Label ranges. Do not pretend a liquor-store rule prices Regulatory approval timeline for buyers.

Inventory and biomass on Regulatory approval timeline for buyers — why does this change Regulatory approval timeline for buyers?

What is on the floor at close has to match the state system. Failed tests and unsold canopy are price, not atmosphere. Count it.

Real estate attached to Regulatory approval timeline for buyers — why does this change Regulatory approval timeline for buyers?

The building can be the deal or the trap. No cannabis-use clause means Regulatory approval timeline for buyers cannot operate after assignment. Sale-leasebacks are capital, not magic.

Social-equity paper inside Regulatory approval timeline for buyers — what breaks Regulatory approval timeline for buyers?

Eligible-transferee rules and holding periods are deal terms. Regulatory approval timeline for buyers that ignores them is a letter, not a close. See social-equity locks.

Distressed paths near Regulatory approval timeline for buyers — what breaks Regulatory approval timeline for buyers?

Receiverships and ABCs exist because chapter 7 and 11 are generally closed to domestic plant-touching debtors. If Regulatory approval timeline for buyers is already in a fiduciary process, price the claims, not last year’s CIM.

The first cut on Regulatory approval timeline for buyers — what breaks Regulatory approval timeline for buyers?

Regulatory approval timeline for buyers is decided before a teaser goes out. buyers who start with a hoped-for multiple skip whether the paper can move. Michigan and Ohio do not share a packet. more than one license class is the lens.

Records that prove Regulatory approval timeline for buyers — what belongs on Regulatory approval timeline for buyers?

Rebuild Regulatory approval timeline for buyers from track-and-trace, tax filings, the lease cannabis-use clause, and a cap table that matches the application. A vanity P&L is a brochure. Buyers spend after-tax cash.

Michigan habits that fail on Regulatory approval timeline for buyers — why does this change Regulatory approval timeline for buyers?

Copying a Michigan habit into Ohio is how Regulatory approval timeline for buyers dies in review. Maryland is the third check. Published locks (Maryland converted control through 1 July 2028; New Jersey majority changes; California non-assignment) only apply if the premises sit there.

Cash after tax on Regulatory approval timeline for buyers — what breaks Regulatory approval timeline for buyers?

Illustrative only: $351,000 of pre-280E earnings can shrink hard on an adult-use book. Medical Schedule III relief after 28 April 2026 is a slice, not a slogan. Dual shops apportion. IRC §280E is the citation.

Capital that will not appear on Regulatory approval timeline for buyers — what belongs on Regulatory approval timeline for buyers?

SBA SOP 50 10 8 still bars plant-touching 7(a) and 504. SAFE Banking Act of 2026, S.4942 is not a close condition. Regulatory approval timeline for buyers is funded with seller paper, private credit, cash, or a sale-leaseback — or it is not funded.

Cited sources that govern Regulatory approval timeline for buyers: SBA SOP 50 10 8 keeps plant-touching targets out of 7(a) and 504, including medical. SAFE Banking Act of 2026, S.4942 and H.R.9471 were introduced in 2026 and are not law. Hemp SKUs must be read against CRS IN12620 on the 2026 hemp definition and CRS IF13136; the redefinition date is 12 November 2026. Federal Register 2026-08176 is the April 2026 medical / FDA-approved marijuana Schedule III order.

What to bring to the intro call — what breaks Regulatory approval timeline for buyers?

Book twenty minutes with Jason Taken at HedgeStone Business Advisors. For Regulatory approval timeline for buyers, bring the license class, the state, the local authorization status, and whether a buyer or target is already in the room. There is no form on this site and no invented listing book. He is a business broker, not an attorney and not a licensed cannabis operator.

Read track-and-trace revenue next if that file is open on Regulatory approval timeline for buyers. buy pillar is the companion page when Regulatory approval timeline for buyers needs that angle. Keep true party of interest in the working set for Regulatory approval timeline for buyers. Read buyer red flags next if that file is open on Regulatory approval timeline for buyers. non-SBA financing is the companion page when Regulatory approval timeline for buyers needs that angle. Keep ownership eligibility in the working set for Regulatory approval timeline for buyers. Read diligence checklist next if that file is open on Regulatory approval timeline for buyers. METRC is the companion page when Regulatory approval timeline for buyers needs that angle.

Summary on Regulatory approval timeline for buyers — why does this change Regulatory approval timeline for buyers?

Regulatory approval timeline for buyers turns on approval, after-tax cash, and the license class. Federal law current as of September 2026 is a schedule split, not a green light. Verify every rate, cap, and clock with counsel.

Which public sources belong on this file?

Keep U.S. Treasury, DEA drug scheduling, DEA diversion schedules, FDA cannabis / CBD page in the working set. A forum post is not a substitute.

How should a buyer screen this Missouri target?

Buyers who tour first waste months. Run eligibility, local host status, and track-and-trace before a site walk. SBA SOP 50 10 8 will not finance plant-touching. Commentary 4x–43x is not a bid. New Jersey and Missouri are different buyboxes; Massachusetts is the third check. The job is to sequence the target, not to fall in love with the storefront.

Buyer screenFail if
EligibilityResidency or TPI issue
Local hostOpt-out or dead CUP
BooksTrack-and-trace mismatch
CapitalSBA assumed

Which eligibility traps hit before a tour?

Buyers who tour first waste months. Run eligibility, local host status, and track-and-trace before a site walk. SBA SOP 50 10 8 will not finance plant-touching. Commentary 5x–53x is not a bid. Maryland and Nevada are different buyboxes; Arizona is the third check. The job is to map the target, not to fall in love with the storefront.

Buyer screenFail if
EligibilityResidency or TPI issue
Local hostOpt-out or dead CUP
BooksTrack-and-trace mismatch
CapitalSBA assumed

How should buyers spend diligence days?

Buyers who tour first waste months. Run eligibility, local host status, and track-and-trace before a site walk. SBA SOP 50 10 8 will not finance plant-touching. Commentary 6x–63x is not a bid. Colorado and Connecticut are different buyboxes; New Jersey is the third check. The job is to rebuild the target, not to fall in love with the storefront.

Buyer screenFail if
EligibilityResidency or TPI issue
Local hostOpt-out or dead CUP
BooksTrack-and-trace mismatch
CapitalSBA assumed

Which capital will not appear?

Buyers who tour first waste months. Run eligibility, local host status, and track-and-trace before a site walk. SBA SOP 50 10 8 will not finance plant-touching. Commentary 3x–33x is not a bid. Michigan and Ohio are different buyboxes; Maryland is the third check. The job is to hold back the target, not to fall in love with the storefront.

Buyer screenFail if
EligibilityResidency or TPI issue
Local hostOpt-out or dead CUP
BooksTrack-and-trace mismatch
CapitalSBA assumed

Frequently asked questions

Does 280E still apply after April 2026?

Adult-use activity stayed Schedule I as of September 2026, so ordinary deductions still fail. Qualifying medical activity moved to Schedule III on 28 April 2026. Dual shops apportion. Read Regulatory approval timeline for buyers against that split, including a Michigan fact pattern. Confirm with a CPA.

Is SAFE Banking a close condition?

No. [SAFE Banking Act of 2026, S.4942](https://www.congress.gov/bill/119th-congress/senate-bill/4942) and [H.R.9471](https://www.congress.gov/bill/119th-congress/house-bill/9471) were introduced, not enacted. Do not underwrite Regulatory approval timeline for buyers on passage.

How long can a license transfer take?

Published clocks vary by state and completeness. Treat 60–180+ days after a complete packet as a broker range unless the agency publishes a deadline. Michigan and Ohio do not share a clock on Regulatory approval timeline for buyers.

Can control move before approval?

Not if you want to keep the license. Stage closing and keep any MSA inside what the statute allows. Regulatory approval timeline for buyers is still an agency event.

Will SBA finance a plant-touching purchase?

No. [SBA SOP 50 10 8](https://www.sba.gov/document/sop-50-10-lender-development-company-loan-programs) treats plant-touching marijuana businesses as ineligible for 7(a) and 504, including medical. Regulatory approval timeline for buyers needs another stack.

What does HedgeStone actually do here?

Eligibility pre-screen, confidential match, METRC-aware pricing, and an approval-contingent process. Not a guaranteed price or a guaranteed yes. That is the job on Regulatory approval timeline for buyers.

Sources

  1. Viridian Capital public commentary — Tier 1 U.S. MSO EV/EBITDA ~4.16x (2025 consensus)
  2. Federal Register 2026-08176 (28 April 2026) — medical / FDA-approved marijuana to Schedule III — https://www.federalregister.gov/d/2026-08176
  3. FinCEN FIN-2014-G001 — BSA expectations for marijuana-related businesses — https://www.fincen.gov/resources/statutes-regulations/guidance/bsa-expectations-regarding-marijuana-related-businesses
  4. SBA SOP 50 10 8 (effective 1 June 2025) — marijuana ineligibility — https://www.sba.gov/document/sop-50-10-lender-development-company-loan-programs
  5. Congress.gov S.4942 — SAFE Banking Act of 2026 (introduced, not enacted) — https://www.congress.gov/bill/119th-congress/senate-bill/4942
  6. U.S. Treasury — https://home.treasury.gov/
  7. DEA drug scheduling — https://www.dea.gov/drug-information/drug-scheduling
  8. DEA diversion schedules — https://www.deadiversion.usdoj.gov/schedules/
  9. Congress.gov H.R.9471 — companion SAFE Banking bill — https://www.congress.gov/bill/119th-congress/house-bill/9471
  10. CRS IF13136 / IN12620 — hemp definition change effective 12 November 2026 (P.L. 119-37) — https://www.congress.gov/crs-product/IN12620
  11. IRC §280E — https://www.law.cornell.edu/uscode/text/26/280E